Accessibility Menu
Health Catalyst Stock Quote

Health Catalyst (NASDAQ: HCAT)

$3.12
(-1.4%)
-0.04
Price as of October 23, 2025, 2:11 p.m. ET

KEY DATA POINTS

Current Price
$3.12
Daily Change
(-1.4%) $0.04
Day's Range
$3.05 - $3.19
Previous Close
$3.16
Open
$3.18
Beta
1.56
Volume
5,871
Average Volume
729,130
Market Cap
222.4M
Market Cap / Employee
$3.16M
52wk Range
$2.52 - $9.24
Revenue
-
Gross Margin
0.32%
Dividend Yield
N/A
EPS
-$1.51
CAPs Rating
-
Industry
Health Care Technology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Health Catalyst Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
HCAT-63.38%-90.85%-38.01%-92%
S&P+14.5%+93.32%+14.09%+123%

Health Catalyst Company Info

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$80.72M6.3%
Gross Profit$25.79M1.5%
Gross Margin31.95%-1.5%
Market Cap$262.40M-30.4%
Market Cap / Employee$0.17M0.0%
Employees1.5K15.4%
Net Income-$40.98M-203.2%
EBITDA$1.02M170.7%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$50.71M-74.9%
Accounts Receivable$68.38M24.6%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$167.28M911.4%
Short Term Debt$5.51M-97.6%

Ratios

Q2 2025YOY Change
Return On Assets-15.31%-3.1%
Return On Invested Capital-19.71%2.2%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$14.19M-482.8%
Operating Free Cash Flow-$9.00M-658.1%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book1.401.210.790.70-34.08%
Price to Sales1.631.441.000.83-34.37%
Price to Tangible Book Value11.219.7414.96-6.10-262.37%
Enterprise Value to EBITDA-211.58-155.56-293.46330.99-249.66%
Return on Equity-21.5%-19.0%-19.8%-28.4%22.77%
Total Debt$364.33M$402.27M$402.37M$172.79M-30.51%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.